Publications
-
Memantine is Associated with Longer Survival than Donepezil in a Veterans Affairs Prescription Database, 1997 to 2008.
Lazzeroni LC,
Halbauer JD, Ashford JW, Noda A, Hernandez B, Azor V, Hozack N, Hasson N, Henderson VW, Yesavage JA, Tinklenberg JR.
J Alzheimers Dis.
2013
-
Circadian clock gene polymorphisms and sleep-wake disturbance in Alzheimer disease.
Yesavage JA,
Noda A, Hernandez B, Friedman L, Cheng JJ, Tinklenberg JR, Hallmayer J, O'hara R, David R, Robert P, Landsverk E, Zeitzer JM.
Am J Geriatr Psychiatry.
2011;
19
(7):
635-43
-
Donepezil treatment and Alzheimer disease: can the results of randomized clinical trials be applied to Alzheimer disease patients in clinical practice?
Tinklenberg JR,
Kraemer HC, Yaffe K, Ross L, Sheikh J, Ashford JW, Yesavage JA, Taylor JL.
Am J Geriatr Psychiatry.
2007;
15
(11):
953-60
-
Statistical and pharmacoeconomic issues for Alzheimer's screening.
Ashford JW,
Kraemer HC, Tinklenberg JR, O'Hara R, Taylor JL, Yesavage JA.
Alzheimers Dement.
2007;
3
(2):
126; discussion 127-31
-
Caution regarding the use of pilot studies to guide power calculations for study proposals.
Kraemer HC,
Mintz J, Noda A, Tinklenberg J, Yesavage JA.
Arch Gen Psychiatry.
2006;
63
(5):
484-9
-
Factors associated with use of medications with potential to impair cognition or cholinesterase inhibitors among Alzheimer's disease patients.
Huey ED,
Taylor JL, Luu P, Oehlert J, Tinklenberg JR.
Alzheimers Dement.
2006;
2
(4):
314-21
-
Factors in choosing atypical antipsychotics: toward understanding the bases of physicians' prescribing decisions.
Hoblyn J,
Noda A, Yesavage JA, Brooks JO, Sheikh J, Lee T, Tinklenberg JR, Schneider B, O'Hara R, Leslie DL, Rosenheck RA, Kraemer HC.
J Psychiatr Res.
2006;
40
(2):
160-6
-
Spatial test for agricultural pesticide "blow-in" effect on prevalence of Parkinson's disease.
Yesavage JA,
Sheikh J, Noda A, Murphy G, O'Hara R, Hierholzer R, Battista M, Ashford JW, Schneider B, Hoblyn J, Kraemer HC, Tinklenberg J.
J Geriatr Psychiatry Neurol.
2006;
19
(1):
32-5
-
The brain-derived neurotrophic factor Val66Met polymorphism and rate of decline in Alzheimer's disease.
Chuu JY,
Taylor JL, Tinklenberg J, Noda A, Yesavage J, Murphy GM.
J Alzheimers Dis.
2006;
9
(1):
43-9
-
Tolerability and effectiveness of lamotrigine in complex elderly patients.
Aulakh JS,
Hawkins JW, Athwal HS, Sheikh JI, Yesavage J, Tinklenberg JR.
J Geriatr Psychiatry Neurol.
2005;
18
(1):
8-11
-
Sleep/wake disruption in Alzheimer's disease: APOE status and longitudinal course.
Yesavage JA,
Friedman L, Kraemer H, Tinklenberg JR, Salehi A, Noda A, Taylor JL, O'Hara R, Murphy G.
J Geriatr Psychiatry Neurol.
2004;
17
(1):
20-4
-
Use of a VA pharmacy database to screen for areas at high risk for disease: Parkinson's disease and exposure to pesticides.
Yesavage JA,
Sheikh J, Noda A, Murphy G, O'Hara R, Hierholzer R, Battista M, Ashford JW, Kraemer HC, Tinklenberg J.
J Geriatr Psychiatry Neurol.
2004;
17
(1):
36-8
-
Validation of a 26-point telephone version of the Mini-Mental State Examination.
Newkirk LA,
Kim JM, Thompson JM, Tinklenberg JR, Yesavage JA, Taylor JL.
J Geriatr Psychiatry Neurol.
2004;
17
(2):
81-7
-
Age and disease severity predict choice of atypical neuroleptic: a signal detection approach to physicians' prescribing decisions.
Yesavage JA,
Hoblyn J, Sheikh J, Tinklenberg JR, Noda A, O'Hara R, Fenn C, Mumenthaler MS, Friedman L, Kraemer HC.
J Psychiatr Res.
2003 Nov-Dec;
37
(6):
535-8
-
On disentangling states versus traits: demonstration of a new technique using the Alzheimer's disease assessment scale.
Taylor JL,
Kraemer HC, Noda A, Friedman L, Zarcone V, Tinklenberg JR, Yesavage JA.
Alzheimer Dis Assoc Disord.
2002 Oct-Dec;
16
(4):
254-60
-
Donepezil and flight simulator performance: effects on retention of complex skills.
Yesavage JA,
Mumenthaler MS, Taylor JL, Friedman L, O'Hara R, Sheikh J, Tinklenberg J, Whitehouse PJ.
Neurology.
2002;
59
(1):
123-5
-
Sleep/wake cycle disturbance in Alzheimer's disease: how much is due to an inherent trait?
Yesavage JA,
Taylor JL, Kraemer H, Noda A, Friedman L, Tinklenberg JR.
Int Psychogeriatr.
2002;
14
(1):
73-81
-
Which Alzheimer patients are at risk for rapid cognitive decline?
O'Hara R,
Thompson JM, Kraemer HC, Fenn C, Taylor JL, Ross L, Yesavage JA, Bailey AM, Tinklenberg JR.
J Geriatr Psychiatry Neurol.
2002;
15
(4):
233-8
-
Event-related brain potential evidence of spared knowledge in Alzheimer's disease.
Ford JM,
Askari N, Mathalon DH, Menon V, Gabrieli JD, Tinklenberg JR, Yesavage J.
Psychol Aging.
2001;
16
(1):
161-76
-
Rate of cognitive decline in AD is accelerated by the interleukin-1 alpha -889 *1 allele.
Murphy GM,
Claassen JD, DeVoss JJ, Pascoe N, Taylor J, Tinklenberg JR, Yesavage JA.
Neurology.
2001;
56
(11):
1595-7
-
Remote memory for public figures in Alzheimer's disease: relationships to regional cortical and limbic brain volumes.
Fama R,
Shear PK, Marsh L, Yesavage JA, Tinklenberg JR, Lim KO, Pfefferbaum A, Sullivan EV.
J Int Neuropsychol Soc.
2001;
7
(3):
384-90
-
A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias.
Hawkins JW,
Tinklenberg JR, Sheikh JI, Peyser CE, Yesavage JA.
Am J Geriatr Psychiatry.
2000;
8
(3):
221-5
-
Alpha2 macroglobulin and the risk of Alzheimer's disease.
Dodel RC,
Du Y, Bales KR, Gao F, Eastwood B, Glazier B, Zimmer R, Cordell B, Hake A, Evans R, Gallagher-Thompson D, Thompson LW, Tinklenberg JR, Pfefferbaum A, Sullivan EV, Yesavage J, Alstiel L, Gasser T, Farlow MR, Murphy GM, Paul SM.
Neurology.
2000;
54
(2):
438-42
-
Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF.
Kahle PJ,
Jakowec M, Teipel SJ, Hampel H, Petzinger GM, Di Monte DA, Silverberg GD, Möller HJ, Yesavage JA, Tinklenberg JR, Shooter EM, Murphy GM.
Neurology.
2000;
54
(7):
1498-504
-
Extent, pattern, and correlates of remote memory impairment in Alzheimer's disease and Parkinson's disease.
Fama R,
Sullivan EV, Shear PK, Stein M, Yesavage JA, Tinklenberg JR, Pfefferbaum A.
Neuropsychology.
2000;
14
(2):
265-76
-
Structural brain correlates of verbal and nonverbal fluency measures in Alzheimer's disease.
Fama R,
Sullivan EV, Shear PK, Cahn-Weiner DA, Marsh L, Lim KO, Yesavage JA, Tinklenberg JR, Pfefferbaum A.
Neuropsychology.
2000;
14
(1):
29-40
-
Brain structural and cognitive correlates of clock drawing performance in Alzheimer's disease.
Cahn-Weiner DA,
Sullivan EV, Shear PK, Fama R, Lim KO, Yesavage JA, Tinklenberg JR, Pfefferbaum A.
J Int Neuropsychol Soc.
1999;
5
(6):
502-9
-
Taking account of between-patient variability when modeling decline in Alzheimer's disease.
Joseph L,
Wolfson DB, Bélisle P, Brooks JO, Mortimer JA, Tinklenberg JR, Yesavage JA.
Am J Epidemiol.
1999;
149
(10):
963-73
-
The stages of Alzheimer's disease: a reappraisal.
Kraemer HC,
Taylor JL, Tinklenberg JR, Yesavage JA.
Dement Geriatr Cogn Disord.
1998 Nov-Dec;
9
(6):
299-308
-
Structural MRI correlates of recognition memory in Alzheimer's disease.
Cahn DA,
Sullivan EV, Shear PK, Marsh L, Fama R, Lim KO, Yesavage JA, Tinklenberg JR, Pfefferbaum A.
J Int Neuropsychol Soc.
1998;
4
(2):
106-14
-
Automatic and effortful processing in aging and dementia: event-related brain potentials.
Ford JM,
Roth WT, Isaacks BG, Tinklenberg JR, Yesavage J, Pfefferbaum A.
Neurobiol Aging.
1997 Mar-Apr;
18
(2):
169-80
-
No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease.
Murphy GM,
Taylor J, Kraemer HC, Yesavage J, Tinklenberg JR.
Am J Psychiatry.
1997;
154
(5):
603-8
-
No association between the alpha 1-antichymotrypsin A allele and Alzheimer's disease.
Murphy GM,
Sullivan EV, Gallagher-Thompson D, Thompson LW, van Duijn CM, Forno LS, Ellis WG, Jagust WJ, Yesavage J, Tinklenberg JR.
Neurology.
1997;
48
(5):
1313-6
-
Selective cortical and hippocampal volume correlates of Mattis Dementia Rating Scale in Alzheimer disease.
Fama R,
Sullivan EV, Shear PK, Marsh L, Yesavage JA, Tinklenberg JR, Lim KO, Pfefferbaum A.
Arch Neurol.
1997;
54
(6):
719-28
-
The apolipoprotein E epsilon 4 allele is associated with increased behavioral disturbance in Alzheimer's disease.
Murphy GM,
Taylor J, Tinklenberg JR, Yesavage JA.
Am J Geriatr Psychiatry.
1997;
5
(1):
88-9
-
An observational study of sexual behavior in demented male patients.
Zeiss AM,
Davies HD, Tinklenberg JR.
J Gerontol A Biol Sci Med Sci.
1996;
51
(6):
M325-9
-
Criminal recidivism predicted from narratives of violent juvenile delinquents.
Tinklenberg JA,
Steiner H, Huckaby WJ, Tinklenberg JR.
Child Psychiatry Hum Dev.
1996;
27
(2):
69-79
-
N400 evidence of abnormal responses to speech in Alzheimer's disease.
Ford JM,
Woodward SH, Sullivan EV, Isaacks BG, Tinklenberg JR, Yesavage JA, Roth WT.
Electroencephalogr Clin Neurophysiol.
1996;
99
(3):
235-46
-
Neurointegrative role of dopamine and GABA in psychosis.
Daigle MS,
Davantzis CT, Sugerman BD, Fenn HF, Tinklenberg JR, Robinson DD.
Ann Pharmacother.
1996;
30
(10):
1197-9
-
Rate of cognitive decline in Alzheimer's disease is not affected by the alpha-1-antichymotrypsin A allele or the CYP2D6 B mutant.
Murphy GM,
Yang L, Yesavage J, Tinklenberg JR.
Neurosci Lett.
1996;
217
(2-3):
200-2
-
Fluoxetine and visual hallucinations in dementia.
Omar SJ,
Robinson D, Davies HD, Miller TP, Tinklenberg JR.
Biol Psychiatry.
1995;
38
(8):
556-8
-
Longitudinal volumetric computed tomographic analysis of regional brain changes in normal aging and Alzheimer's disease.
Shear PK,
Sullivan EV, Mathalon DH, Lim KO, Davis LF, Yesavage JA, Tinklenberg JR, Pfefferbaum A.
Arch Neurol.
1995;
52
(4):
392-402
-
Possible oral lactate exacerbation of panic disorder.
Robinson D,
Casso DE, Omar SJ, Tinklenberg JR.
Ann Pharmacother.
1995;
29
(5):
539-40
-
'How far' vs 'how fast' in Alzheimer's disease. The question revisited.
Kraemer HC,
Tinklenberg J, Yesavage JA.
Arch Neurol.
1994;
51
(3):
275-9
-
Selected psychiatric symptoms associated with rate of cognitive decline in patients with Alzheimer's disease.
Miller TP,
Tinklenberg JR, Brooks JO, Fenn HH, Yesavage JA.
J Geriatr Psychiatry Neurol.
1993 Oct-Dec;
6
(4):
235-8
-
Influence of aging and practice on piloting tasks.
Morrow D,
Yesavage J, Leirer V, Tinklenberg J.
Exp Aging Res.
1993 Jan-Mar;
19
(1):
53-70
-
An ACTH 4-9 analog (Org 2766) and cognitive performance: high-dose efficacy and safety in dementia of the Alzheimer's type.
Miller TP,
Fong K, Tinklenberg JR.
Biol Psychiatry.
1993;
33
(4):
307-9
-
Cognitive decline in Alzheimer's disease: elaborating on the nature of the longitudinal factor structure of the Mini-Mental State Examination.
Brooks JO,
Yesavage JA, Taylor J, Friedman L, Tanke ED, Luby V, Tinklenberg J.
Int Psychogeriatr.
1993;
5
(2):
135-46
-
Development of aphasia, apraxia, and agnosia and decline in Alzheimer's disease.
Yesavage JA,
Brooks JO, Taylor J, Tinklenberg J.
Am J Psychiatry.
1993;
150
(5):
742-7
-
Greater abnormalities of brain cerebrospinal fluid volumes in younger than in older patients with Alzheimer's disease.
Sullivan EV,
Shear PK, Mathalon DH, Lim KO, Yesavage JA, Tinklenberg JR, Pfefferbaum A.
Arch Neurol.
1993;
50
(4):
359-73
-
Reverse transcription and polymerase chain reaction technique for quantification of mRNA in primary astrocyte cultures.
Murphy GM,
Jia XC, Yu AC, Lee YL, Tinklenberg JR, Eng LF.
J Neurosci Res.
1993;
35
(6):
643-51
-
The time-course of alcohol impairment of general aviation pilot performance in a Frasca 141 simulator.
Morrow D,
Yesavage J, Leirer V, Dolhert N, Taylor J, Tinklenberg J.
Aviat Space Environ Med.
1993;
64
(8):
697-705
-
'Til death do us part: intimacy and sexuality in the marriages of Alzheimer's patients.
Davies HD,
Zeiss A, Tinklenberg JR.
J Psychosoc Nurs Ment Health Serv.
1992;
30
(11):
5-10
-
Alzheimer's disease. Beta-amyloid precursor protein expression in the nucleus basalis of Meynert.
Murphy GM,
Greenberg BD, Ellis WG, Forno LS, Salamat SM, Gonzalez-DeWhitt PA, Lowery DE, Tinklenberg JR, Eng LF.
Am J Pathol.
1992;
141
(2):
357-61
-
Astrocytic gliosis in the amygdala in Down's syndrome and Alzheimer's disease.
Murphy GM,
Ellis WG, Lee YL, Stultz KE, Shrivastava R, Tinklenberg JR, Eng LF.
Prog Brain Res.
1992:
94
475-83
-
Correlates of memory decline: a 4-year longitudinal study of older adults with memory complaints.
Taylor JL,
Miller TP, Tinklenberg JR.
Psychol Aging.
1992;
7
(2):
185-93
-
Timing of sleep and wakefulness in Alzheimer's disease patients residing at home.
Bliwise DL,
Tinklenberg JR, Yesavage JA.
Biol Psychiatry.
1992;
31
(11):
1163-5
-
Alzheimer's disease: beta-amyloid precursor protein mRNA expression in mononuclear blood cells.
Allen JS,
Murphy GM, Eng LF, Stultz KE, Davies HD, Pickford LB, Tinklenberg JR.
Neurosci Lett.
1991;
132
(1):
109-12
-
Cognitive decline in patients with Alzheimer disease: differences in patients with and without extrapyramidal signs.
Miller TP,
Tinklenberg JR, Brooks JO, Yesavage JA.
Alzheimer Dis Assoc Disord.
1991;
5
(4):
251-6
-
A quantitative analysis of CT and cognitive measures in normal aging and Alzheimer's disease.
Pfefferbaum A,
Sullivan EV, Jernigan TL, Zipursky RB, Rosenbloom MJ, Yesavage JA, Tinklenberg JR.
Psychiatry Res.
1990;
35
(2):
115-36
-
Antigenic profile of plaques and neurofibrillary tangles in the amygdala in Down's syndrome: a comparison with Alzheimer's disease.
Murphy GM,
Eng LF, Ellis WG, Perry G, Meissner LC, Tinklenberg JR.
Brain Res.
1990;
537
(1-2):
102-8
-
Beta-amyloid precursor detected in human cerebral cortex.
Murphy GM,
Eng LF, Cordell B, Wang Y, Ellis WG, Meissner L, Tinklenberg JR.
Prog Neuropsychopharmacol Biol Psychiatry.
1990;
14
(3):
309-17
-
Pertussis toxin and 4-aminopyridine differentially affect the hypnotic-anesthetic action of dexmedetomidine and pentobarbital.
Doze VA,
Chen BX, Tinklenberg JA, Segal IS, Maze M.
Anesthesiology.
1990;
73
(2):
304-7
-
The incidence and correlates of erectile problems in patients with Alzheimer's disease.
Zeiss AM,
Davies HD, Wood M, Tinklenberg JR.
Arch Sex Behav.
1990;
19
(4):
325-31
-
Sleep apnea in Alzheimer's disease.
Bliwise DL,
Yesavage JA, Tinklenberg JR, Dement WC.
Neurobiol Aging.
1989 Jul-Aug;
10
(4):
343-6
-
REM latency in Alzheimer's disease.
Bliwise DL,
Tinklenberg J, Yesavage JA, Davies H, Pursley AM, Petta DE, Widrow L, Guilleminault C, Zarcone VP, Dement WC.
Biol Psychiatry.
1989;
25
(3):
320-8
-
A comparison of assessment techniques measuring the effects of methylphenidate, secobarbital, diazepam and diphenhydramine in abstinent alcoholics.
Miller TP,
Taylor JL, Tinklenberg JR.
Neuropsychobiology.
1988;
19
(2):
90-6
-
Association study between Alzheimer's disease and restriction fragment length polymorphisms at the human amyloid beta protein gene locus.
Taylor JE,
Tinklenberg JR, Eng LF, Yesavage JA, Vinogradov S, Davies HG, Gonzalez-DeWhitt PA, Frossard PM.
Mol Biol Med.
1988;
5
(3):
167-72
-
Associations between Alzheimer's disease and RFLPs at the human amyloid beta protein gene locus.
Tinklenberg JR,
Taylor JE, Eng LF, Yesavage JA, Vinogradov S, Gonzalez PA, Davies HD, Frossard PM.
Psychopharmacol Bull.
1988;
24
(3):
489-91
-
EcoT14I RFLP found at the human amyloid beta protein gene locus.
Taylor JE,
Cordell B, Fuller F, Gonzalez-DeWhitt PA, Tinklenberg JR, Davies HD, Eng LF, Yesavage JA, Frossard PM.
Nucleic Acids Res.
1988;
16
(13):
6259
-
Human amyloid beta protein gene locus: HaeIII RFLP.
Taylor JE,
Gonzalez-DeWhitt PA, Fuller F, Cordell B, Tinklenberg JR, Davies HD, Eng LF, Yesavage JA, Frossard PM.
Nucleic Acids Res.
1988;
16
(14B):
7217
-
Patterns of behavior in adolescent rape.
Vinogradov S,
Dishotsky NI, Doty AK, Tinklenberg JR.
Am J Orthopsychiatry.
1988;
58
(2):
179-87
-
Desamino-D-arginine-vasopressin (DDAVP) in Alzheimer's disease.
Peabody CA,
Davies H, Berger PA, Tinklenberg JR.
Neurobiol Aging.
1986 Jul-Aug;
7
(4):
301-3
-
Alzheimer's disease syndrome.
Thornton JE,
Davies HD, Tinklenberg JR.
J Psychosoc Nurs Ment Health Serv.
1986;
24
(5):
16-22
-
Microcomputerized testing of drug effects on divided attention.
Thornton JE,
Taylor JL, Gibson EL, Miller TP, Tinklenberg JR.
Psychopharmacol Bull.
1986;
22
(1):
73-5
-
Olfactory deficits and Alzheimer's disease.
Warner MD,
Peabody CA, Flattery JJ, Tinklenberg JR.
Biol Psychiatry.
1986;
21
(1):
116-8
-
Progressive dementia associated with thyroid disease.
Peabody CA,
Thornton JE, Tinklenberg JR.
J Clin Psychiatry.
1986;
47
(2):
100
-
Thyrotropin-releasing hormone (TRH) and Alzheimer's disease.
Peabody CA,
Deblois TE, Tinklenberg JR.
Am J Psychiatry.
1986;
143
(2):
262-3
-
Thyrotropin-releasing hormone stimulation test and Alzheimer's disease.
Peabody CA,
Minkoff JR, Davies HD, Winograd CH, Yesavage J, Tinklenberg JR.
Biol Psychiatry.
1986;
21
(5-6):
553-6
-
A psychopharmacological perspective of cognitive functions. I. Theoretical overview and methodological considerations.
Wolkowitz OM,
Tinklenberg JR, Weingartner H.
Neuropsychobiology.
1985;
14
(2):
88-96
-
A psychopharmacological perspective of cognitive functions. II. Specific pharmacologic agents.
Wolkowitz OM,
Tinklenberg JR, Weingartner H.
Neuropsychobiology.
1985;
14
(3):
133-56
-
Desglycinamide-9-arginine-8-vasopressin (DGAVP, Organon 5667) in patients with dementia.
Peabody CA,
Thiemann S, Pigache R, Miller TP, Berger PA, Yesavage J, Tinklenberg JR.
Neurobiol Aging.
1985;
6
(2):
95-100
-
Naloxone's effect on cognitive functioning in drug-free and diazepam-treated normal humans.
Wolkowitz OM,
Tinklenberg JR.
Psychopharmacology (Berl).
1985;
85
(2):
221-3
-
Olfactory deficits and primary degenerative dementia.
Peabody CA,
Tinklenberg JR.
Am J Psychiatry.
1985;
142
(4):
524-5
-
Dual task performance measures in geriatric studies.
Tinklenberg JR,
Taylor JL, Peabody CA, Redington D, Gibson E.
Psychopharmacol Bull.
1984;
20
(3):
441-4
-
Neuropeptides in geriatric psychopharmacology.
Tinklenberg JR,
Thornton JE.
Psychopharmacol Bull.
1983;
19
(2):
198-211
-
[Computerized tests of attention, memory and motor performance applied to geriatric research].
Yesavage JA,
Tinklenberg JR.
Presse Med.
1983;
12
(48):
3170-2
-
CT measures of cerebrospinal fluid volume in alcoholics and normal volunteers.
Jernigan TL,
Zatz LM, Ahumada AJ, Pfefferbaum A, Tinklenberg JR, Moses JA.
Psychiatry Res.
1982;
7
(1):
9-17
-
Desglycinamide-9-arginine-8-vasopressin (DGAVP, Organon 5667) in cognitively impaired patients.
Tinklenberg JR,
Pigache R, Berger PA, Kopell BS.
Psychopharmacol Bull.
1982;
18
(4):
202-4
-
Effect of nafronyl on lactate and pyruvate in the cerebrospinal fluid of patients with senile dementia.
Yesavage JA,
Tinklenberg JR, Hollister LE, Berger PA.
J Am Geriatr Soc.
1982;
30
(2):
105-8
-
Effects of perceptual and cognitive difficulty on P3 and RT in young and old adults.
Ford JM,
Pfefferbaum A, Tinklenberg JR, Kopell BS.
Electroencephalogr Clin Neurophysiol.
1982;
54
(3):
311-21
-
Drugs and criminal assaults by adolescents: a replication study.
Tinklenberg JR,
Murphy P, Murphy PL, Pfefferbaum A.
J Psychoactive Drugs.
1981 Jul-Sep;
13
(3):
277-87
-
Acute phencyclidine (PCP) intoxication: quantitative urine levels and clinical management.
Walker S,
Yesavage JA, Tinklenberg JR.
Am J Psychiatry.
1981;
138
(5):
674-5
-
Single-case study of clinical response to high-dose ergot alkaloid treatment for dementia. Preliminary report.
Yesavage JA,
Tinklenberg JR.
Gerontology.
1981;
27
(1-2):
76-8
-
[Pharmacological therapy of senile dementia in Europe and the U.S.A].
Yesavage JA,
Tinklenberg JR, Berger PA, Masson JM, Martin A, Bourgeois M.
Ann Med Psychol (Paris).
1981;
139
(1):
21-8
-
Auditory brain stem and cortical evoked potentials in schizophrenia.
Pfefferbaum A,
Horvath TB, Roth WT, Tinklenberg JR, Kopell BS.
Biol Psychiatry.
1980;
15
(2):
209-23
-
Choline chloride effects on memory in the elderly.
Mohs RC,
Davis KL, Tinklenberg JR, Hollister LE.
Neurobiol Aging.
1980;
1
(1):
21-5
-
Cholinomimetics and memory. The effect of choline chloride.
Davis KL,
Mohs RC, Tinklenberg JR, Hollister LE, Pfefferbaum A, Kopell BS.
Arch Neurol.
1980;
37
(1):
49-52
-
Human memory and the effects of physostigmine and choline chloride [proceedings].
Davis KL,
Mohs RC, Davis BM, Horvath TB, Tinklenberg JR, Rosenberg GS, Levy MI.
Psychopharmacol Bull.
1980;
16
(4):
27-8
-
Sensitivity of some human cognitive functions to effects of methamphetamine and secobarbital.
Mohs RC,
Tinklenberg JR, Roth WT, Kopell BS.
Drug Alcohol Depend.
1980;
5
(2):
145-50
-
Choline chloride treatment of memory deficits in the elderly.
Mohs RC,
Davis KL, Tinklenberg JR, Hollister LE, Yesavage JA, Kopell BS.
Am J Psychiatry.
1979;
136
(10):
1275-7
-
EEG effects of physostigmine and choline chloride in humans.
Pfefferbaum A,
Davis KL, Coulter CL, Mohs RC, Tinklenberg JR, Kopell BS.
Psychopharmacology (Berl).
1979;
62
(3):
225-33
-
Enhancement of memory by physostigmine.
Davis KL,
Mohs RC, Tinklenberg JR.
N Engl J Med.
1979;
301
(17):
946
-
Human EEG response to beta-endorphin.
Pfefferbaum A,
Berger PA, Elliott GR, Tinklenberg JR, Kopell BS, Barchas JD, Li CH.
Psychiatry Res.
1979;
1
(1):
83-8
-
Phenylethylamine in rhesus monkeys: interactions with alpha-methyl-para-tyrosine and l-dopa.
Tinklenberg JR,
Gillin JC, Murphy GM, Staub R, Wyatt RJ.
Am J Psychiatry.
1979;
136
(3):
311-3
-
The effects of ethanol and meperidine on auditory evoked potentials.
Pfefferbaum A,
Roth WT, Tinklenberg JR, Rosenbloom MJ, Kopell BS.
Drug Alcohol Depend.
1979;
4
(5):
371-80
-
Vasodilators in senile dementias: a review of the literature.
Yesavage JA,
Tinklenberg JR, Hollister LE, Berger PA.
Arch Gen Psychiatry.
1979;
36
(2):
220-3
-
Buss-Durkee assessment and validation with violent versus nonviolent chronic alcohol abusers.
Renson GJ,
Adams JE, Tinklenberg JR.
J Consult Clin Psychol.
1978;
46
(2):
360-1
-
Marijuana effects on associations to novel stimuli.
Tinklenberg JR,
Darley CF, Roth WT, Pfefferbaum A, Kopell BS.
J Nerv Ment Dis.
1978;
166
(5):
362-4
-
Methamphetamine and diphenhydramine effects on the rate of cognitive processing.
Mohs RC,
Tinklenberg JR, Roth WT, Kopell BS.
Psychopharmacology (Berl).
1978;
59
(1):
13-9
-
Physostigmine: improvement of long-term memory processes in normal humans.
Davis KL,
Mohs RC, Tinklenberg JR, Pfefferbaum A, Hollister LE, Kopell BS.
Science.
1978;
201
(4352):
272-4
-
Slowing of short-term memory scanning in alcoholics.
Mohs RC,
Tinklenberg JR, Roth WT, Kopell BS.
J Stud Alcohol.
1978;
39
(11):
1908-15
-
The distribution of attention across auditory input channels: an assessment using the human evoked potential.
Hink RF,
Fenton WH, Pfefferbaum A, Tinklenberg JR, Kopell BS.
Psychophysiology.
1978;
15
(5):
466-73
-
The effects of phenylethylamine in rhesus monkeys.
Tinklenberg JR,
Gillin JC, Murphy GM, Staub R, Wyatt RJ.
Am J Psychiatry.
1978;
135
(5):
576-8
-
Time course effects of marijuana and ethanol on event-related potentials.
Kopell BS,
Roth WT, Tinklenberg JR.
Psychopharmacology (Berl).
1978;
56
(1):
15-20
-
Vigilance and human attention under conditions of methylphenidate and secobarbital intoxication: an assessment using brain potentials.
Hink RF,
Fenton WH, Tinklenberg JR, Pfefferbaum A, Kopell BS.
Psychophysiology.
1978;
15
(2):
116-25
-
Ethanol and marihuana effects on event-related potentials in a memory retrieval paradigm.
Roth WT,
Tinklenberg JR, Kopell BS.
Electroencephalogr Clin Neurophysiol.
1977;
42
(3):
381-8
-
Marijuana and memory intrusions.
Pfefferbaum A,
Darley CF, Tinklenberg JR, Roth WT, Kopell BS.
J Nerv Ment Dis.
1977;
165
(6):
381-6
-
Marijuana effects on long-term memory assessment and retrieval.
Darley CF,
Tinklenberg JR, Roth WT, Vernon S, Kopell BS.
Psychopharmacology (Berl).
1977;
52
(3):
239-41
-
Cannabis and alcohol effects on assaultiveness in adolescent delinquents.
Tinklenberg JR,
Roth WT, Kopell BS, Murphy P.
Ann N Y Acad Sci.
1976:
282
85-94
-
Marijuana and ethanol: differential effects on time perception, heart rate, and subjective response.
Tinklenberg JR,
Roth WT, Kopell BS.
Psychopharmacology (Berl).
1976;
49
(3):
275-9
-
Mood states and 24-hour cardiac monitoring.
Roth WT,
Tinklenberg JR, Doyle CM, Horvath TB, Kopell BS.
J Psychosom Res.
1976;
20
(3):
179-86
-
Parameters of temporal recovery of the human auditory evoked potential.
Roth WT,
Krainz PL, Ford JM, Tinklenberg JR, Rothbart RM, Kopell BS.
Electroencephalogr Clin Neurophysiol.
1976;
40
(6):
623-32
-
Marihuana effects on TAT form and content.
Roth WT,
Rosenbloom MJ, Darley CF, Tinklenberg JR, Kopell BS.
Psychopharmacologia.
1975;
43
(3):
261-6
-
Reliability of the contingent negative variation and the auditory evoked potential.
Roth WT,
Kopell BS, Tinklenberg JR, Huntsberger GE, Kraemer HC.
Electroencephalogr Clin Neurophysiol.
1975;
38
(1):
45-50
-
The contingent negative variation during a memory retrieval task.
Roth WT,
Kopell BS, Tinklenberg JR, Darley CF, Sikora R, Vesecky TB.
Electroencephalogr Clin Neurophysiol.
1975;
38
(2):
171-4
-
What a physician should know about marihuana.
Tinklenberg JR,
Ration Drug Ther.
1975;
9
(7):
1-6
-
Drug involvement in criminal assaults by adolescents.
Tinklenberg JR,
Murphy PL, Murphy P, Darley CF, Roth WT, Kopell BS.
Arch Gen Psychiatry.
1974;
30
(5):
685-9
-
Drug use among youthful assaultive and sexual offenders.
Tinklenberg JR,
Woodrow KM.
Res Publ Assoc Res Nerv Ment Dis.
1974:
52
209-24
-
Proceedings: Drugs, delinquency, and aggression.
Tinklenberg JR,
Kopell BS, Roth WT, Darley C.
Psychopharmacol Bull.
1974;
10
(4):
62-3
-
Temporal disorganization and delusional-like ideation. Processes induced by hashish and alcohol.
Melges FT,
Tinklenberg JR, Deardorff CM, Davies NH, Anderson RE, Owen CA.
Arch Gen Psychiatry.
1974;
30
(6):
855-61
-
The effects of methamphetamine and secobarbital on the contingent negative variation amplitude.
Kopell BS,
Wittner WK, Lunde DT, Wolcott LJ, Tinklenberg JR.
Psychopharmacologia.
1974;
34
(1):
55-62
-
The nature of storage deficits and state-dependent retrieval under marihuana.
Darley CF,
Tinklenberg JR, Roth WT, Atkinson RC.
Psychopharmacologia.
1974;
37
(4):
139-49
-
Marihuana and retrieval from short-term memory.
Darley CF,
Tinklenberg JR, Hollister TE, Atkinson RC.
Psychopharmacologia.
1973;
29
(3):
231-8
-
Subchronic oral doses of marihuana extract.
Hollister LE,
Tinklenberg JR.
Psychopharmacologia.
1973;
29
(3):
247-52
-
The effect of marihuana on tracking task performance.
Roth WT,
Tinklenberg JR, Whitaker CA, Darley CF, Kopell BS, Hollister LE.
Psychopharmacologia.
1973;
33
(3):
259-65
-
Contingent negative variation amplitudes. Marihuana and alcohol.
Kopell BS,
Tinklenberg JR, Hollister LE.
Arch Gen Psychiatry.
1972;
27
(6):
809-11
-
Marihuana and alcohol, Time production and memory functions.
Tinklenberg JR,
Kopell BS, Melges FT, Hollister LE.
Arch Gen Psychiatry.
1972;
27
(6):
812-5
-
A clinical view of the amphetamines.
Tinklenberg JR,
Am Fam Physician.
1971;
4
(5):
82-6
-
Marihuana and the temporal span of awareness.
Melges FT,
Tinklenberg JR, Hollister LE, Gillespie HK.
Arch Gen Psychiatry.
1971;
24
(6):
564-7
-
The personal future and self-esteem.
Melges FT,
Anderson RE, Kraemer HC, Tinklenberg JR, Weisz AE.
Arch Gen Psychiatry.
1971;
25
(6):
494-7
-
Management of "bad trips" in an evolving drug scene.
Taylor RL,
Maurer JI, Tinklenberg JR.
JAMA.
1970;
213
(3):
422-5
-
Marihuana and temporal disintegration.
Melges FT,
Tinklenberg JR, Hollister LE, Gillespie HK.
Science.
1970;
168
(3935):
1118-20
-
Marijuana and immediate memory.
Tinklenberg JR,
Melges FT, Hollister LE, Gillespie HK.
Nature.
1970;
226
(5251):
1171-2
-
Temporal disintegration and depersonalization during marihuana intoxication.
Melges FT,
Tinklenberg JR, Hollister LE, Gillespie HK.
Arch Gen Psychiatry.
1970;
23
(3):
204-10
Navigation for This Section: Psychiatry
Find a Researcher
Help
Internal Staff Login